FeesSafety
Pluang+

Citigroup raises Krystal Biotech price target on Vyjuvek sales and promising KB113 trial results

Analyst Insights
16 Oct 2026, 01:03 WIB
Rayan Ahmad
View Source
Bullish
Citigroup raises Krystal Biotech price target on Vyjuvek sales and promising KB113 trial results

Citigroup increased its price target for Krystal Biotech to $416 from $386, citing strong Q2 revenue of $119.2 million from its approved product Vyjuvek and encouraging early clinical data for KB113, a treatment for basal cell carcinomas in Gorlin syndrome. Vyjuvek's success supports a solid financial position with $1.1 billion in cash and a 40% operating margin. The positive KB113 trial results, showing lesion shrinkage and mild side effects in three patients, will be presented at the PeDRA Annual Conference, indicating potential growth for Krystal Biotech's pipeline and stock value.

Krystal Biotech's recent strong Q2 revenue of $119.2 million and a robust $1.1 billion cash position provide important context. For readers following the health sector, here is Pluang's market snapshot as of Oct 16, 2026 00:41 WIB: out of 150 priced US health stocks, 137 rose and 12 fell. Notable movers include Moderna (MRNA) at USD 238.25 with a 5.28% gain and 83% buy order activity, Elanco Animal Health (ELAN) up 5.19% at USD 23.72, and Alumis Inc. (ALMS) rising 4.95% to USD 6.36 with 100% buy orders and a typical hold time of 0 days.

More News

New nonprofit Software Safety Institute launches to reduce harm from insecure software.

New nonprofit Software Safety Institute launches to reduce harm from insecure software.

The Software Safety Institute (SSI), a new independent nonprofit, has launched to tackle preventable harm caused by unsafe and insecure software. SSI aims to improve software safety by changing industry incentives and practices through research, publ...

Market News
Neutral
1 hour ago
Silvercrest ranks #8 in Nasdaq eVestment Q3 2026 Brand Awareness among mid-sized asset managers

Silvercrest ranks #8 in Nasdaq eVestment Q3 2026 Brand Awareness among mid-sized asset managers

Silvercrest Asset Management Group Inc. was ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings among mid-sized firms managing $2.5 billion to $40 billion in assets. This ranking reflects strong engagement from consultants and asset owne...

Market News
Bullish
1 hour ago
AST SpaceMobile to report Q3 earnings amid satellite network expansion and new Japan joint venture

AST SpaceMobile to report Q3 earnings amid satellite network expansion and new Japan joint venture

AST SpaceMobile is set to report its Q3 2026 earnings with an expected loss of $0.42 per share and revenue of $45.7 million. The company is advancing its satellite network technology, including a new joint venture with Rakuten to build a direct-to-de...

Company Fundamentals
Neutral
2 hours ago
AnorTech closes $7.55M share exchange, Greenland Mines now owns 19.9% stake

AnorTech closes $7.55M share exchange, Greenland Mines now owns 19.9% stake

AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...

Company Fundamentals
Bullish
2 hours ago
Neo launches Neoverse, a free AI security engine analyzing 4M+ AI apps to block malicious software automatically.

Neo launches Neoverse, a free AI security engine analyzing 4M+ AI apps to block malicious software automatically.

Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App